TABLE 1

Associations of GRPR, SSTR2, and CXCR4 mRNA Levels in LNN M0 Patients

GRPR mRNA (x10−2)SSTR2 mRNA (x10−2)CXCR4 mRNA (x10−2)
CharacteristicNo. of patients*Percentage of patientsMedianInterquartile rangeMedianInterquartile rangeMedianInterquartile range
All patients in this cohort684100%0.727.070.581.7511.7813.13
Age at surgery (y)
 ≤40609%1.1712.720.902.9914.0613.75
 41–5525237%0.979.200.611.6411.5813.18
 56–7021832%0.525.380.521.6812.1911.34
 >7015423%0.724.440.621.619.9912.98
P0.520.680.0403
Menopausal status
 Premenopausal27340%1.2610.950.621.8211.8113.73
 Postmenopausal41160%0.604.870.551.5711.7612.12
P0.130.530.39
Surgery
 Lumpectomy37855%0.617.690.571.8211.6713.15
 Ablation30645%0.906.790.601.5611.9013.00
P0.690.590.65
Pathologic tumor size
 pT130745%1.258.540.691.8712.0313.40
 pT2 + unknown35151%0.415.250.511.6511.5312.84
 pT3 + pT4264%0.583.050.501.3812.1913.53
P0.00140.240.92
ESR1 mRNA status
 Negative < 0.218427%0.090.130.280.4214.7413.83
 Positive ≥ 0.250073%2.4610.980.812.5910.9812.16
P<0.001<0.001<0.001
PGR mRNA status
 Negative < 0.128542%0.120.320.320.5614.3614.31
 Positive ≥ 0.139958%3.6712.681.022.9810.4511.09
P< 0.001<0.001<0.001
ERBB2 mRNA status
 Negative < 1857484%0.998.280.611.9211.6412.96
 Positive ≥ 1810716%0.301.510.491.0013.8813.32
P<0.0010.03440.22
Grade (GGI)
 122733%2.4210.460.752.1110.8311.03
 222933%0.896.920.632.4111.4414.59
 322433%0.131.420.340.9813.8313.58
P<0.001<0.001<0.001
Percentage invasive tumor cells
 ≤70%47069%0.816.840.631.8812.5713.92
 >70%21431%0.648.280.431.289.1310.70
P0.870.002<0.001
  • * Because of missing numbers, not all categories add up to 684.

  • P for Mann–Whitney U or Kruskal–Wallis test when appropriate.

  • ESR1, PGR, and ERBB2 were determined by real-time PCR; cut points were as follows: ESR1 = 0.2, PGR = 0.1, and ERBB2 = 18.0 (mRNA level relative to reference gene set).

  • P for Spearman rank-correlation test.